SEC Form 4 · accession 0000899243-18-031133
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Maduck
Officer — See Remarks
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | M | 44,991 | $2.61 | A | 65,015 | D | |
| Common Stock | Dec 12, 2018 | M | 15,009 | $3.29 | A | 80,024 | D | |
| Common StockF1 | Dec 12, 2018 | S | 60,000 | $19.0061 | D | 20,024 | D | |
| Common Stock | Dec 13, 2018 | M | 10,000 | $2.24 | A | 30,024 | D | |
| Common StockF2 | holding | — | — | — | 10,000 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 10,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $2.61 | Dec 12, 2018 | M | 44,991 | D | — | Aug 7, 2024 | Common Stock | 44,991 | 55,009 | D |
| Stock Option (Right to Buy)F5 | $3.29 | Dec 12, 2018 | M | 15,009 | D | — | Feb 18, 2025 | Common Stock | 15,009 | 234,991 | D |
| Stock Option (Right to Buy)F4 | $2.24 | Dec 13, 2018 | M | 10,000 | D | — | Nov 1, 2022 | Common Stock | 10,000 | 25,000 | D |
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- F2Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F3Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
- F4Fully exercisable.
- F5Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 18, 2015, so that the total number of shares subject to this option becomes fully vested and exercisable on February 18, 2019.
Remarks
Senior Vice President, Commercial